News Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 10:05:08 06/03/2026 pm IST			5-day change	1st Jan Change
4.200 ^GBX	0.00%		-6.67%	+5.00%

26/12	Certain Ordinary Shares of Poolbeg Pharma PLC are subject to a Lock-Up Agreement Ending on 26-DEC-2025.	CI
08/12	Poolbeg Pharma plc Announces the POLB 001 Trial Is to Feature in Cancer Immunotherapy-Induced CRSResearch Programme	CI

All News

26/12	Certain Ordinary Shares of Poolbeg Pharma PLC are subject to a Lock-Up Agreement Ending on 26-DEC-2025.	CI
08/12	Poolbeg Pharma plc Announces the POLB 001 Trial Is to Feature in Cancer Immunotherapy-Induced CRSResearch Programme	CI
20/11	Poolbeg Pharma Secures European Patent for Severe Influenza Drug Candidate	MT
20/11	AIM WINNERS & LOSERS: Artisanal in shutdown hit; Solid State deal wins	AN
20/11	Poolbeg Pharma plc Receives European Immunomodulator II Patent Application Covering POLB 001 for the Treatment of Severe Influenza	CI
01/25/01	Poolbeg Pharma PLC - Shareholder/Analyst Call
29/25/29	EARNINGS: Silver Bullet bookings rise; Blackbird hits milestones	AN
29/25/29	Poolbeg Pharma PLC Reports Earnings Results for the Half Year Ended June 30, 2025	CI
26/25/26	Centaur Media to return cash after latest disposal	AN
25/25/25	Poolbeg Pharma Enlists Accelerating Clinical for POLB 001 Trial	MT
25/25/25	Poolbeg Pharma plc Signs an Agreement for A Specialist Blood Cancer Trials Organization, Accelerating Clinical Trials Limited to Conduct the Upcoming POLB 001 Phase 2A Trial and Secures the Supply of an Approved Bispecific Antibody Drug for the Trial At No Cost to the Company	CI
29/25/29	Poolbeg Pharma PLC - Shareholder/Analyst Call
27/25/27	Poolbeg Pharma shares up after US FDA orphan drug designation	AN
27/25/27	AIM WINNERS & LOSERS: React Group swings to loss and lowers outlook	AN
27/25/27	Poolbeg Pharma's POLB 001 Wins Orphan Drug Designation in US	MT
27/25/27	Poolbeg Granted FDA Orphan Drug Designation For POLB 001	RE
23/25/23	POLB 001: tackling cytokine storms before they start	AQ
23/25/23	Poolbeg Pharma Raises GBP5 Million Via Upsized Bookbuild	MT
23/25/23	Poolbeg upsizes offer; Glenveagh backs outlook	AN
21/25/21	Poolbeg upsizes fundraise amid strong investor demand	AN
20/25/20	Poolbeg Pharma Raises GBP4.7 Million via Placing, Subscription	MT
20/25/20	Poolbeg Pharma PLC Reports Earnings Results for the Full Year Ended December 31, 2024	CI
20/25/20	Poolbeg Pharma loss widens; launches GBP4 million equity raise	AN
20/25/20	Poolbeg Pharma Launches GBP4.1 Million Conditional Fundraise via Share Issue	MT
20/25/20	Earnings Flash (POLB.L) Poolbeg Pharma Reports FY24 Loss GBX-1.16	MT